The Europe CT market size was USD 1.94 Billion in 2022 and is likely to reach USD 3.32 Billion by 2031, expanding at a CAGR of 6.16% during 2023–2031. The growth of the market is attributed to the rising prevalence of chronic diseases and recent developments in the healthcare sector.
The rising prevalence of chronic diseases, for example, oncology, cardiovascular, and neurology disorders has prompted to indulge in early diagnosis services. Computed tomography (CT) is a medical imaging system generally utilized in medical care equipment for diagnostic and therapeutic purposes. The improvements in the medical care area has fueled the interest for advanced imaging systems, including CT systems.
The coronavirus pandemic affected the worldwide market due to the disturbance in the supply chain and manufacturing activities during the lockdown. While the COVID-19 pandemic has seriously affected most business sectors, internationally, the medical device market is one that has experienced polarizing impacts of the pandemic.
The quick spread of the pandemic has brought about healthcare systems being overpowered, with assets and staff being re-coordinated to address the surge in the number of patients.
Market Trends, Drivers, Restraints, and Opportunities
-
Rising prevalence of the targeted diseases is one of the key factors fueling the market growth.
-
Growing geriatric population is estimated to accelerate the growth of the market.
-
Increasing number of technological advanced devices is estimated to drive the market growth.
-
Growing patient emphasis on effective and early disease diagnosis is one of the major factors driving the market growth.
-
Procedural benefits offered by CT is expected to contribute to the growth of the market during the forecast period.
-
Significant installation and maintenance costs can restrain the growth of the market.
-
Rising demand for ongoing market shift toward image-guided interventions is expected to create lucrative opportunity for the Europe CT market.
Scope of Europe Computed Tomography (CT) Market Report
The report on the Europe CT market includes an assessment of the market, trends, segments, and Geography markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
CT Market - Europe Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Types (Low Slice, Medium Slice and High Slice), Applications (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Others), End-users (Hospitals, Diagnostic Centers, and Others)
|
Geographical Scope
|
The UK, Germany, Italy, France, the Netherlands, and Rest of Europe
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Koninklijke Philips NV; Hitachi Medical Systems; GE Healthcare; Canon Medical Systems; Siemens AG; and Fujifilm Holdings Corporation
|
Europe CT Market Segment Insights
Low slice segment is expected to grow at a robust pace
Based on types, the market is segregated into low slice, medium slice, and high slice. The low slice segment is anticipated to account for a significant market share during the forecast period. Low slice scanners in emerging countries along with the established and strong product portfolio of market players in this segment are driving the segment growth.
The technological advancements in low-slice scanners and low pricing as compared to high-end devices have been instrumental in augmenting the demand for low-slice products across the world. However, the low slice scanners segment is anticipated to hold a key share of the market in the coming years due to increasing demand for the opportunities in treatment methods.
Oncology segment is projected to dominate the market
On the basis of applications, the Europe CT market is segregated into oncology, neurology, cardiovascular, musculoskeletal, and others. The oncology segment is projected to expand at a considerable CAGR during the forecast period. CT systems are widely used in the detection of tumors and other cancer medical abnormalities.
A rise in the usage of imaging modalities for the diagnosis of the diseases is expected to spur the segment growth. Increasing prevalence of cancer due to the rising geriatric population and the rising adoption of CT systems in cancer diagnosis are major factors fueling the segment growth.

Hospitals segment is anticipated to constitute a key market share
Base on end-users, the market is categorized as hospitals, diagnostic centers, and others. The hospitals segment held a substantial market share in 2020. Hospitals are an integral part of the healthcare sector and are a major revenue source for the entire industry, which fosters the research and innovation.
The UK o constitute a considerable market share
In terms of geography, the market is classified as the UK, Germany, Italy, France, the Netherlands, and the Rest of Europe. The UK is anticipated to account for a significant market share during the forecast period. The market in Europe is expected to account for the high share in terms of revenue owing to the increasing demand for latest technologies in the country.
Segments
The Europe CT market has been segmented on the basis of
Types
- Low Slice
- Medium Slice
- High Slice
Applications
- Oncology
- Neurology
- Cardiovascular
- Musculoskeletal
- Others
End-users
- Hospitals
- Diagnostic Centers
- Others
Geography
- The UK
- Germany
- Italy
- France
- Netherlands
- Rest of Europe
Key Players
Competitive Landscape
Key players competing in the Europe CT market are Koninklijke Philips NV; Hitachi Medical Systems; GE Healthcare; Canon Medical Systems; Siemens AG; and Fujifilm Holdings Corporation. Companies are engaging in partnerships, acquisitions, and mergers to expand their market share.
